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Intended Audience 
These surveillance guidelines were developed for local, state, and territorial health departments and cities in 
the United States receiving Epidemiology and Laboratory Capacity cooperative agreement funding.  
 
Part 1: Guidelines for Conducting Surveillance and for Reporting 
Presence, Absence, and Relative Abundance of Aedes aegypti and Aedes 
albopictus 
Background 
Aedes aegypti and Aedes albopictus, known vectors of Zika, dengue, and chikungunya viruses, are present 
in parts of the United States. They are the only known members of the Aedes sub-genus Stegomyia, the 
most important vectors of these viruses, known to occur in the continental United States. Maps on the CDC 
website (http://www.cdc.gov/zika/vector/range.html) show the areas where these mosquitoes are known or 
suspected to occur. Ae. aegypti is more common in the warmer, southern states. Ae. albopictus occurs over 
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a greater range and can extend into more temperate climates. Both species can, however, be introduced 
seasonally to areas with climates unlikely to allow overwintering. Such introductions may initiate and sustain 
temporary local transmission of arboviruses during the warm part of the year.  
 
Surveillance Aims 
• To improve knowledge of the distribution and local abundance of Ae. aegypti and Ae. albopictus in 
the United States. 
• To produce and publically post regularly updated mosquito distribution maps.  
 
This information should be used to guide vector surveillance and control activities targeting Ae. aegypti- and 
Ae. albopictus-borne arboviral diseases in the continental United States. 
 
Surveillance Recommendations 
A) Surveillance should be conducted in each county where Ae. aegypti or Ae. albopictus are likely to be 
found. As many locations as possible should be monitored in these counties (especially 
cities/towns). More locations in the surveillance program will increase the chances of detecting these 
mosquitoes, if they are present, thus providing information necessary for developing accurate 
distribution maps. Negative surveillance results are important information, and reporting of such 
negative results to CDC is strongly encouraged but might not provide definitive evidence for 
absence of these species within a county. 
 
B) Ae. aegypti is adapted to human habitations; it is less likely to be found in rural areas, parkland, or 
other open or sparsely populated areas. Ae. albopictus can be found in a wider variety of habitats 
including wooded, forested, and rural areas away from population centers, as well as human 
habitations. The best locations for Ae. aegypti and Ae. albopictus surveillance are 
- Highly populated urban/suburban centers 
- Tire dumps, trash dump sites, junk yards, and cemeteries 
- Port cities, cities along rivers, and cities with high commercial traffic 
- Historic urban areas, which have many underground hibernation sites 
 
C) Using higher numbers of traps per surveillance location increases the chances of detecting Ae. 
aegypti and Ae. albopictus. Methods should be used to survey for adults as well as immature stages 
and mosquito eggs. Of the methods available, the least expensive are sampling from containers and 
distributing ova collection cups. Traps that collect adults are relatively expensive and their 
usefulness might differ between regions; for example, in the desert of the Southwest, light traps are 
reported to efficiently sample Ae. aegypti (Monaghan et al. 2016). Collection specifics can be 
modified based on professional local experience with the targeted mosquito species, but collection 
should be systematic. 
- Adult Ae. aegypti and Ae. albopictus can be sampled by using 
i. BG-Sentinel Trap® (http://www.bg-sentinel.com/). This trap targets blood meal-
seeking female mosquitoes. It can be used with a proprietary lure (BG-Lure®). Similar 
to BG-Sentinel traps, light traps target blood meal seeking females. Light traps have 
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been reported to be effective in the arid Southwest but less so elsewhere. Relative 
abundance can be reported as the number of mosquitoes collected per trap per day. 
ii. Autocidal Gravid Ovitrap (AGO) (https://springstar.net/store/). This trap targets 
gravid female mosquitoes. Ovipositing females get stuck to the adhesive on the 
oviposition substrate. Relative abundance can be reported as the number of 
mosquitoes collected per trap per day. 
iii. Mechanical collections with aspirators. Hand-held or backpack aspirators can be 
used to sample resting mosquitoes indoors or outdoors. Outdoors, these mosquitoes 
usually rest under vegetation or in shaded corners; indoors, they are often found in 
closets and other undisturbed, dark places. Relative abundance can be reported as 
number of mosquitoes collected per unit time of active sampling; for example the 
number of mosquitoes collected at a site in 15 minutes.  
 
- Immature stages are sampled by examining water-holding containers for larvae and pupae. 
Because of the wide variety of water-holding containers in which the mosquitoes can be 
found, there is no standard equipment for sampling immature stages. When possible, the 
entire water content should be emptied onto a tray or a pan and the immature stages picked 
out using a dropper. Larger containers can be sampled by using dippers or utensils of 
various size (e.g., turkey basters, pipettes, or ladles). The entire contents may be poured 
through sieves to strain out immature mosquito stages. The aim is to collect a representative 
sample; the higher the number of locations inspected the more representative the sample.  
With experience, the third and fourth instar larvae can be identified microscopically 
(Farajollahi and Price 2013), but the easiest, albeit slower, means of identifying immature 
stages is to rear them to adults. Care should be taken to ensure data on original collection 
sites are not lost in the rearing process.  
From the data collected, larval and pupal indices are calculated. Commonly used indices 
include the House Index (HI), the Container Index (CI), the Breteau Index (BI), and pupal 
surveys to estimate the number of pupae per house, per person, or per hectare. Further 
descriptions of these indices can be found at 
https://www.cdc.gov/chikungunya/resources/vector-control.html. 
 
- Egg sampling is conducted using ovitraps (ovicups). Ovitraps are small black containers 
made of glass or plastic, which contain water or hay infusion and a substrate (typically a strip 
of paper, such as coffee filter or germination paper) on which females lay their eggs. Ovitraps 
are simple, inexpensive and easy to deploy. CDC uses black plastic 22 oz. souvenir cups 
(giacona.com, product MTC22T) and Anchor Paper 
(http://www.anchorpaper.com/index.php/seed-solutions/germination-
papers/#heavyweightpaper, product SD 7606) as oviposition substrates. Anchor Paper is cut 
into 10 by 3 inch pieces and placed inside the cups.  Eggs should be reared out in the 
laboratory and identified to species as adults to ensure definitive species identification. Data 
should be reported as number of eggs per trap per day. More information can be found at 
https://www.cdc.gov/chikungunya/resources/vector-control.html. 
 
- Some state/county health departments and mosquito abatement districts are already using 
light traps and CDC gravid traps to survey for the Culex vectors of West Nile virus. Setting 
traps specifically for Ae. aegypti and Ae. albopictus at some of these locations, if they include 
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suitable collection environments, may reduce sampling time and effort. To avoid interference 
between types of traps 
 Where light traps are being operated, only ovitraps and AGO traps should be 
deployed. 
 Where CDC gravid traps are installed, only BG Sentinel traps should be used.  
 
D) Surveillance should begin when daytime maximum outdoor temperatures consistently reach 50°F 
(10°C) and continue as long as these temperatures are maintained. BG-Sentinel traps should be 
checked daily, AGO traps should be checked once or twice a week, and ovitraps at least every 3 
days. Sampling multiple days a week is recommended to compensate for weather variations that 
may affect sampling efficiency. In areas with seasonal mosquito activity, surveillance may be 
discontinued when daytime maximum outdoor temperatures consistently drop below 50°F or after 
the first frost. For areas where daytime maximum outdoor temperatures do not drop below 50°F, 
surveillance should be conducted year-round. The same sites for trapping should, as far as possible, 
be used throughout the season and between years to provide a basis for comparison over time. It 
might be necessary to move traps or increase the number of traps used in sectors where an 
outbreak is occurring or control efforts must be monitored. 
 
E) Recording data. Accurate records are essential. A unique identification number should be assigned 
to each collection. Additionally, the following minimum information should be recorded:  
- Collection location  
i. City/town and county 
ii. Neighborhood/address 
iii. GPS coordinates 
- Habitat type 
- Life stage targeted 
- Collection method 
- Collection date 
- Presence of eggs, larvae or pupae of Ae. aegypti or Ae. albopictus 
- Number of Ae. aegypti or Ae. albopictus adults, separately by sex 
 
Reporting to CDC 
CDC has launched the MosquitoNET online portal to collect data for mosquito presence and abundance, 
and for insecticide resistance testing. The MosquitoNET portal can be accessed at  
http://www.cdc.gov/zika/vector/for-professionals.html. Following initial set-up of a user account, monthly 
data reporting is required. 
 
CDC Use of Reported Data 
The data will be used to regularly update distribution maps of Ae. aegypti and Ae. albopictus in the United 
States. The maps will be posted on a CDC website accessible to the general public. The data will be used 
to guide surveillance and control efforts against Ae. aegypti and Ae. albopictus and their associated 
arboviruses.  
 
For further questions on mosquito surveillance, contact: CDCMosqSurveillance@cdc.gov  
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Part 2: Insecticide Resistance Testing for Known Mosquito Vectors of 
Zika, Dengue, and Chikungunya Viruses 
 
Background 
Insecticides to control larval and adult stages of Aedes aegypti and Aedes albopictus are important 
components of an integrated mosquito management (IMM) program. With frequent use, insecticide 
resistance (IR) may develop, particularly with insecticides used for adult control. Systematic resistance 
testing is an important tool for choosing the types of insecticides that will be most effective. Recent 
insecticide resistance testing for Ae. aegypti in Puerto Rico provides an excellent example of how 
systematically generated data on spatial patterns of resistance to specific insecticides can be displayed as 
maps (http://www.cdc.gov/zika/vector/insecticideresistancetesting.html) and used to guide emergency 
control efforts.  
 
Testing Aims 
To better enable local, state, and national programs to effectively respond to epidemics of Zika, 
chikungunya, and dengue viruses through control of Ae. aegypti and Ae. albopictus. An additional aim is to 
improve our knowledge of evolving geographical patterns of insecticide resistance and devise programs for 
managing it.  
 
CDC Testing Recommendations 
A) Testing strategy 
- Testing of mosquito populations should occur at least once a year to monitor for changes in 
insecticide susceptibility.   
- Testing should be done before selection of insecticide products to be used in the next 
mosquito season.  
- Testing should be done in every municipality where mosquito control is conducted. 
- It is important to determine which public health insecticides have been used in an area during 
the past 5 years. Testing by using technical grade active ingredients should be done for all 
adulticides that are currently or were recently used locally. In some areas, the ancillary 
effects of agricultural insecticides might contribute to resistance. It is also useful to test active 
ingredients not currently used but commercially available, in order to be prepared should an 
alternative insecticide be needed. Adulticide active ingredients currently registered for use in 
the United States are malathion, naled, chlorpyrifos, permethrin, sumethrin (d-phenothrin), 
prallethrin, deltamethrin, etofenprox, and pyrethrins. 
- To ensure that local resistance has not developed in mosquitoes due to use of pesticides for 
reasons other than mosquito control, a quick resistance assessment should be done before 
emergency adulticiding, even in areas where no mosquito control was conducted during the 
past 5 years. 
-  
B) Testing methods 
- The CDC bottle bioassay 
(http://www.cdc.gov/parasites/education_training/lab/bottlebioassay.html) should be used for 
testing.  
- The primary goal is to determine local susceptibility of Ae. aegypti and Ae. albopictus to the 
main classes of insecticides. By 2017 or earlier, it should be a goal to also establish 
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Knowledge of resistance mechanisms can more precisely guide choice of alternate 
chemicals. 
- Resistance mechanisms can be determined by using a variety of assays. At a minimum, the
CDC bottle bioassay can be used to assess resistance mechanisms by adding enzyme
inhibitors for the 3 classes of metabolic enzymes that can be overexpressed, resulting in
resistance. These inhibitors counteract overexpression of enzymes and can be used to
determine which enzyme class is responsible for the observed resistance (see: using these
inhibitors [http://www.cdc.gov/parasites/education_training/lab/bottlebioassay.html]).
Additional testing to measure expression of resistance enzymes (microplate assays) and
molecular tests can also be performed (McAllister et al. 2012, Scott and McAllister 2012).
C) General notes on mosquitoes used for testing
- Approximately 125 mosquitoes per chemical per site are needed to run a test. Results will be
most accurate if adults collected the same day from the same site are used. Because of their
relative scarcity, this may not be practical in all cases.
- Pooling of test mosquitoes from a large geographic area should be avoided if at all possible
because the overall results for the larger area can mask local insecticide resistance.
- If necessary, field collected females allowed to oviposit in the laboratory can be used to
generate mosquitoes for testing. Insecticide resistance assays should be conducted with the
first generation brood if possible, because successive blood feeding of mosquitoes to
generate large specimen numbers for testing can either mask or overestimate the level of
resistance in a population.
- Mosquitoes used for testing should be collected from the same locality each year.
Specific notes on collection of mosquitoes for testing 
- Mosquitoes may be obtained as part of routine surveillance activities by adding additional
traps at existing surveillance locations (see Part 1).
- The BG Sentinel trap or ovicups can be used to collect live Ae. aegypti and Ae. albopictus
specimens. This may result in collection of a mixture of mosquito species, and some effort
will be required to separate the species for testing.
- Adult mosquitoes that have been collected in traps should be allowed to recover for 12-24
hours before testing to allow for those damaged by trapping, e.g., from fan blades, to die.
D) The following information on mosquitoes used should be recorded:
- Collection identification number
- Sample origin location(s)




- Life stage collected
- Species and generation being tested
E) The following bottle assay information should be recorded for reporting to CDC:
- Active ingredient and, if used, inhibitor
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- Concentration(s) (µg/bottle)  
- Time between bottle preparation and testing 
- Number of mosquitoes tested 
- Diagnostic time and total test time 
- Percent mortality at diagnostic time and, if applicable, end of test 
- Time 100% mortality achieved 
 
Reporting to CDC 
CDC has launched the MosquitoNET online portal to collect data for mosquito presence and abundance, 
and for insecticide resistance testing. The MosquitoNET portal can be accessed at:  
http://www.cdc.gov/zika/vector/for-professionals.html. Following initial set-up of a user account, monthly 
data reporting is required. 
 
CDC Use of Reported Data 
The data will be used to develop and regularly update maps for resistance to insecticides in Ae. aegypti and 
Ae. albopictus in the United States. The maps will be posted on a CDC website, still under development, 
accessible to the general public. The data will be used to guide the choice of insecticides for emergency 
control efforts against Ae. aegypti and Ae. albopictus and their associated arboviruses, and to inform 
insecticide resistance management planning. 
 
For further questions on insecticide resistance, contact: CDCInsectResistance@cdc.gov 
 
Addendum 1: Overview of insecticide Resistance Testing Algorithm 
 
Addendum 2: Extended Background on Insecticide Resistance 
With the use of insecticides comes the possibility that insecticide resistance (IR) may develop, particularly 
with insecticides used for adult control. Currently, two classes of insecticides are used on adult mosquitoes, 
organophosphates and pyrethroids. These two classes are also used for agriculture, urban pest control, 
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homeowners and mosquito control for over 40 years. If insecticides are used in a program, then routine 
testing for IR should also be conducted to assure that an effective product is being used.  
IR is a genetic change in response to selection by toxicants that may impair control in the field. (Sawicki, 
1987). This definition allows for recognizing the development of resistance and altering control techniques 
to mitigate it before the use of a particular chemical is lost. The most direct way to test for IR is to perform a 
phenotypic assay, known as the CDC bottle bioassay (Brogdon and McAllister, 1998), which measures the 
amount of time it takes for an insecticide to get to the target site and act on that site. A target site is the 
tissue that an insecticide interacts with to cause mortality. There are other less direct ways to measure 
resistance, which include assessing relative changes in doses required to kill 50% of a population 
(sometimes difficult to interpret), or comparing responses of caged susceptible colonies and field collected 
mosquitoes (labor intensive and dependent on stringent environmental conditions that one has no control 
over). In addition, both tests require relatively large numbers of mosquitoes compared to the CDC bottle 
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